Development of p-Coumaric Acid Analysis in Human Plasma and Its Clinical Application to PK/PD Study
Open Access
- 30 December 2020
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (1) , 108
Abstract
It has been recognized that p-Coumaric acid (p-CA) has protective effects as an antioxidant, anti-inflammatory agent. A sensitive and efficient Liquid Chromatography-Mass Spectrometry (LC-MS) method for maximum determination of p-CA in human plasma has been established using Ultra-performance liquid Chromatography-tandem mass Spectrometry (UPLC-MS/MS). This study provides the developed analysis of p-CA extracted from Bambusae Caulis in Taeniam (BC) to examine the improvement of the treatment p-CA, IGF-1 and Osteocalcin level in human children which are important factors on the growth of children’s height through Pharmacokinetics/Pharmacodynamics (PK/PD) model. p-CA and internal standard in a plasma sample were detected by the Multiple Reaction Monitoring (MRM) scan mode with positive ion detection. The sample participating in the study was made of 34 subjects (placebo = 18, treatment = 16). The subjects were enrolled to be randomized to the control group and BC group. Randomized subjects took tested treatment twice a day, three capsules with oral administration (258 mg/capsule) each time after a meal. Standard calibration curves (reproducibility) were constructed and the lower limit of quantitation (LLOQ) for p-CA was found to be 0.2 ng/mL on injection of the sample into the UPLC-MS/MS system. Accuracy and precision were evaluated and the intra-accuracy was 99.2–103.8% with precision of 1.0–5.6% and inter-accuracy was 99.6–108.4% and precision of 1.3–6.4% for p-CA. The method has been successfully applied to PK/PD studies of p-CA in human plasma. The p-CA, BC in Taeniam extract increased the level of IGF-1 and Osteocalcin, and changed the height from baseline, which suggested that the p-CA could play an important role in longitudinal bone growth. Therefore, the p-CA extracted from BC in Taeniam might be a good alternative medicine to growth hormone (GH) therapy.Keywords
This publication has 18 references indexed in Scilit:
- Aqueous Extract of Bambusae Caulis in Taeniam Inhibits PMA-Induced Tumor Cell Invasion and Pulmonary Metastasis: Suppression of NF-κB Activation through ROS SignalingPLOS ONE, 2013
- The effect of GH and IGF1 on linear growth and skeletal development and their modulation by SOCS proteinsJournal of Endocrinology, 2010
- Evaluation of antiulcer activity of the main phenolic acids found in Brazilian Green PropolisJournal of Ethnopharmacology, 2008
- Mode of Growth Hormone Action in OsteoblastsJournal of Biological Chemistry, 2007
- Recombinant growth hormone for idiopathic short stature in children and adolescentsCochrane Database of Systematic Reviews, 2007
- Antihyperlipidemic and antihypertensive effect of a triterpenoid‐rich extract from bamboo shavings and vasodilator effect of friedelin on phenylephrine‐induced vasoconstriction in thoracic aortas of ratsPhytotherapy Research, 2007
- Investigating the role of the growth hormone–insulin-like growth factor (GH–IGF) axis as a determinant of male bone mineral density (BMD)Bone, 2005
- Insulin-like growth factor-I and insulin-like growth factor-II induce c-fos in mouse osteoblastic cellsCalcified Tissue International, 1990
- Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developmentsJournal of Endocrinology, 1989
- Pulsatile Intravenous Growth Hormone (GH) Infusion to Hypophysectomized Rats Increases Insulin-Like Growth Factor I Messenger Ribonucleic Acid in Skeletal Tissues More Effectively than Continuous GH Infusion*Endocrinology, 1988